Lv1
65 积分 2021-07-21 加入
Evaluation of the safety and efficacy of recombinant factor IX (nonacog alfa) in minimally treated and previously treated Chinese patients with haemophilia B
22天前
已完结
The past and future of haemophilia: diagnosis, treatments, and its complications
22天前
已完结
Factor IX pharmacokinetics: differences between plasma‐derived and recombinant products and the clinical and economic implications: a meeting report
22天前
已完结
Haemophilia management and treatment: An Italian survey on patients’, caregivers’ and clinicians’ point of view
22天前
已完结
Pharmacokinetic, efficacy and safety evaluation of B‐domain‐deleted recombinant FVIII (SCT800) for prophylactic treatment in adolescent and adult patients with severe haemophilia A
22天前
已完结
Pattern of bleeding in a large prospective cohort of haemophilia A patients: A three‐year follow‐up of the AHEAD (Advate in HaEmophilia A outcome Database) study
22天前
已完结
The demographics, treatment characteristics and quality of life of adult people with haemophilia in China – results from the HERO study
22天前
已完结
Targeting HER2 heterogeneity in breast and gastrointestinal cancers
1个月前
已完结
Moment of Addition of LH to the Culture Medium Improves In Vitro Survival and Development of Secondary Goat Pre‐antral Follicles
1个月前
已完结
皖公网安备34019202002308
